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BACKGROUND: Bowel dysfunction after low anterior 
resection is often assessed by determining the low 
anterior resection syndrome score. What is unknown, 
however, is whether this syndrome is already present in 
the general population and which nonsurgical factors are 
associated.
OBJECTIVE: The purpose of this study was to determine 
the prevalence of minor and major low anterior resection 
syndrome in the general Dutch population and which 
other factors are associated with this syndrome.
DESIGN: This was a cross-sectional study.
SETTINGS: The study was conducted within the general 
Dutch population.
PATIENTS: The Groningen Defecation and Fecal 
Continence Questionnaire was distributed among a 
general Dutch population-based sample (N = 1259).
MAIN OUTCOME MEASURES: Minor and major low 
anterior resection syndrome were classified according to 
the scores obtained.
RESULTS: The median, overall score was 16 (range, 0–42). 
Minor low anterior resection syndrome was more prevalent 
than the major form (24.3% vs 12.2%; p < 0.001). Bowel 
disorders, including fecal incontinence, constipation, 
and irritable bowel syndrome were associated with the 
syndrome, whereas sex, age, BMI, and vaginal delivery 
were not. Remarkably, patients with diabetes mellitus were 
significantly more prone to experience minor or major low 
anterior resection syndrome. The ORs were 2.8 (95% CI, 
1.8–4.4) and 3.7 (95% CI, 2.2–6.2).
LIMITATIONS: We selected frequent comorbidities and 
other patient-related factors that possibly influence the 
syndrome. Additional important factors do exist and 
require future research.
CONCLUSIONS: Minor and major low anterior resection 
syndrome occur in a large portion of the general Dutch 
population and even in a healthy subgroup. This implies 
that the low anterior resection syndrome score can only be 
used to interpret the functional result of the low anterior 
resection provided that a baseline measurement of each 
individual is available. Furthermore, because people 
with low anterior resection syndrome often experience 
constipation and/or fecal incontinence, direct examination 
and diagnosis of these conditions might be a more efficient 
approach to treating patient bowel dysfunctions. See Video 
Abstract at http://links.lww.com/DCR/B110.
¿CÓMO DEBE INTERPRETARSE LA PUNTUACIÓN DEL 
SÍNDROME DE RESECCIÓN ANTERIOR BAJA?
Funding/Support: None reported.
Financial Disclosures: None reported.
Aia M. A. Al-Saidi and Sanne J. Verkuijl contributed equally to this work.
Poster presentation at the Alpine Colorectal Meeting 2019, Wengen, 
Switzerland, January 27 to 29, 2019.
Correspondence: Sanne J. Verkuijl, B.Sc., and Aia Al-Saidi, M.D., De-
partment of Surgery, Anorectal Physiology Laboratory, University of 
Groningen, University Medical Center Groningen, Hanzeplein 1, PO 
Box 30 001, 9700 RB Groningen, the Netherlands. E-mail: s.j.verkuijl@
umcg.nl or a.m.a.al-saidi@umcg.nl 
How Should the Low Anterior Resection Syndrome 
Score Be Interpreted?
Aia M. A. Al-Saidi, M.D.1 • Sanne J. Verkuijl, B.Sc.1 • Sijbrand Hofker, M.D.2   
Monika Trzpis, Ph.D.1 • Paul M. A. Broens, M.D., Ph.D.1,3
1 Anorectal Physiology Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, 
Groningen, the Netherlands
2 Division of Abdominal Surgery, Department of Surgery, University of Groningen, University Medical Center Groningen, 
Groningen, the Netherlands
3 Division of Pediatric Surgery, Department of Surgery, University of Groningen, University Medical Center Groningen, 
Groningen, the Netherlands
Dis Colon Rectum 2020; 63: 520–526
DOI: 10.1097/DCR.0000000000001561
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, 
Inc. on behalf of the American Society of Colon and Rectal Surgeons. 
This is an open-access article distributed under the terms of the Crea-
tive Commons Attribution-Non Commercial-No Derivatives License 
4.0 (CCBY-NC-ND), where it is permissible to download and share the 
work provided it is properly cited. The work cannot be changed in any 
way or used commercially without permission from the journal.
ORIGINAL CONTRIBUTION
DISEASES OF THE COLON & RECTUM VOLUME 63: 4 (2020) 521
ANTECEDENTES: La disfunción intestinal después de la 
resección anterior baja a menudo se evalúa determinando 
la puntuación del síndrome de resección anterior baja. 
Sin embargo, lo que se desconoce es si este síndrome ya 
está presente en la población general y qué factores no 
quirúrgicos están asociados.
OBJETIVO: Determinar la prevalencia del síndrome de 
resección anterior baja menor y mayor en la población 
holandesa general y qué otros factores están asociados 
con este síndrome.
DISEÑO: Estudio transversal.
CONFIGURACIÓN: Población holandesa general.
PACIENTES: El cuestionario de defecación y continencia 
fecal de Groningen se distribuyó entre una muestra 
general de población holandesa (N = 1259).
PRINCIPALES MEDIDAS DE RESULTADO: El síndrome de 
resección anterior baja menor y mayor se clasificó de 
acuerdo con las puntuaciones obtenidas.
RESULTADOS: La mediana de la puntuación general 
fue de 16.0 (rango 0-42). El síndrome de resección 
anterior baja menor fue más frecuente que la forma 
principal (24.3% versus 12.2%, (P <0.001). Los 
trastornos intestinales, incluyendo incontinencia fecal, 
estreñimiento y síndrome del intestino irritable se 
asociaron con el síndrome, mientras que el sexo, la 
edad y el cuerpo el índice de masa y el parto vaginal no 
lo hicieron. Notablemente, los pacientes con diabetes 
mellitus fueron significativamente más propensos 
a experimentar el síndrome de resección anterior 
baja menor o mayor. Las razones de probabilidad 
fueron 2.8 (IC 95%, 1.8-4.4) y 3.7 (IC 95%, 2.2 -6.2), 
respectivamente.
LIMITACIONES: Se seleccionaron las comorbilidades 
frecuentes y otros factores relacionados con el paciente 
que posiblemente influyen en el síndrome. Existen otros 
factores importantes que requieren investigación en el 
futuro.
CONCLUSIONES: El síndrome de resección anterior baja 
menor y mayor ocurre en una gran parte de la población 
holandesa general e incluso en un subgrupo sano. Esto 
implica que la puntuación del síndrome de resección 
anterior baja solo se puede utilizar para interpretar el 
resultado funcional de la resección anterior baja, siempre 
que esté disponible una medición inicial de cada individuo. 
Además, dado que las personas con síndrome de resección 
anterior baja a menudo experimentan estreñimiento y/o 
incontinencia fecal, el examen directo y el diagnóstico 
de estas afecciones pueden ser un enfoque más eficiente 
para tratar las disfunciones intestinales de los pacientes. 
Consulte Video Resumen en http://links.lww.com/DCR/
B110. (Traducción—Dr. Gonzalo Hagerman)
KEY WORDS:  Anterior resection; Bowel dysfunction; Low 
anterior resection syndrome; Rectal cancer.
Low anterior resection is a common colorectal sur-gical procedure. Nevertheless, many patients re-port severe postoperative bowel dysfunction. It is 
assumed that the bowel complaints arise subsequent to 
the resection.1,2 As a consequence, this complex of bowel 
complaints is referred to as low anterior resection syn-
drome (LARS). It is manifested by a broad spectrum of 
symptoms, including incontinence for flatus and/or liquid 
stool, clustering of stools, fecal urgency, and an extremely 
high or low frequency of bowel movements.1
The LARS score was designed in 2012 as a quick tool 
to assess functional outcome of patients after low anterior 
resection for rectal cancer.3 Subsequently, the LARS score 
was translated into different languages and validated for 
different countries and has become a frequently used tool 
in both clinical practice and research.4–6 The prevalence of 
minor LARS after low anterior resection for rectal cancer 
is between 22% and 28%. The prevalence for major LARS 
is between 38% and 62%.6 Remarkably, a recent article 
by Juul et al7 stated that major LARS is not restricted to 
patients who had undergone a low anterior resection. It 
also occurs in the general population, where prevalence is 
highest, up to 18.8%, in 50- to 79-year–old women.7 As far 
as we know, the prevalence of minor LARS in the general 
population has not yet been described.
Bowel dysfunction is not only caused by abdominal 
surgery; age and sex are 2 other known influences.8 It is un-
clear what extent these factors and others, such as obstetric 
history or comorbidities, contribute to LARS symptoms. It 
would seem that the current use and interpretation of the 
LARS score requires refinement.
Our first aim therefore was to explore the prevalence 
of minor and major LARS in the general Dutch popula-
tion and in a subpopulation without the comorbidities 
known to influence bowel function. Second, we aimed to 
determine which factors, other than low anterior resec-
tion, contribute significantly to minor or major LARS.
PATIENTS AND METHODS
Study Design
For this retrospective cross-sectional study, Survey Sam-
pling International (Rotterdam, the Netherlands) invited 
members of the general Dutch population to fill out the 
digital Defecation and Fecal Continence Questionnaire in 
2015 to form a population-based sample (N = 1259).9,10 
A random selection of the respondents was made to ar-
rive at a representative cohort according to the population 
pyramid of the Netherlands, with sex, age, and region e-
qually distributed.9 The survey was designed in such a way 
that all of the questions had to be answered, thus  yielding 
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a database without missing data. The completed ques-
tionnaires provided us with a comprehensive overview 
of bowel functioning and possible bowel-related symp-
toms, including LARS symptoms. The Defecation and Fe-
cal Continence Questionnaire has been validated in the 
Dutch population.10
Study Groups
First, we analyzed the entire sample irrespective of respon-
dents’ medical history. Second, we performed a subanaly-
sis of 2 subgroups formed on the basis of comorbidities 
known to influence bowel function. This subanalysis was 
performed to estimate the prevalence of LARS in respon-
dents whose bowel functions were, at least theoretically, 
healthy. Therefore, the subgroup without comorbidities 
consisted of the respondents who had reported not hav-
ing any comorbidities known to influence bowel func-
tion, such as surgery for bowel (n = 32), fistula (n = 15), 
anus (n = 16), hemorrhoids (n = 28), prostate (n = 16), 
Hirschsprung disease (n = 3), teratomas (n = 1), or vaginal 
and abdominal hysterectomy (n = 75). Respondents who 
reported experiencing one of the following comorbidities, 
which are known to influence bowel function, were also 
excluded from this subgroup: Crohn’s disease or ulcera-
tive colitis (n = 14), irritable bowel syndrome (IBS; n = 
99), rectal prolapse (n = 17), diabetes mellitus (n = 114), 
cerebrovascular accidents (n = 20), neurologic disorders 
(n = 18), slow transit constipation (n = 6), anorectal mal-
formation (n = 1), sacrococcygeal teratoma (n = 2), or 
spina bifida (n = 1). The comorbidities subgroup consist-
ed of the respondents who had reported experiencing at 
least 1 of the above-mentioned comorbidities.
Assessment of Fecal Disorders
We diagnosed minor and major LARS based on 5 items of 
the LARS score, as described by Emmertsen and Laurb-
erg3: incontinence for flatus and/or liquid stool, frequency 
of bowel movements, clustering of the stools, and fecal ur-
gency. Respondents who scored <21 points did not have 
LARS. Respondents who scored 21 to 29 points experienced 
minor LARS, whereas 30 to 42 points indicated major LARS.
We defined constipation, fecal incontinence (FI), and 
IBS in accordance with the Rome IV criteria.11,12 In case 
of constipation, respondents had to comply with at least 2 
of these criteria during the last 3 months, with symptom 
onset at least 6 months before diagnosis: >25% defecation 
straining, lumpy or hard stools, incomplete evacuation, 
anorectal blockage, manual maneuvers to support defe-
cation, <3 spontaneous bowel movements per week, and 
loose stools rarely present without previous use of laxa-
tives. To meet the criteria for FI, respondents had to ex-
perience recurrent involuntary passage of fecal material 
(solid or liquid stool), including soiling, occurring at least 
2 to 4 times during 4 weeks over the last 6 months. In case 
of IBS, respondents had to comply with at least 2 of the 
following criteria: recurrent abdominal pain on average at 
least 1 day per week during the last 3 months and associ-
ated with 2 or more of the following: defecation, a change 
in stool frequency, and a change in the appearance of stool.
Statistical Analysis
IBM SPSS Statistics, version 23.0 (IBM Corp, Armonk, NY), 
was used for statistical analyses. The data represented by con-
tinuous variables were not distributed normally and are pre-
sented as medians with ranges. The Kruskall–Wallis test was 
used to compare such data. Categorical variables were pre-
sented as numbers and percentages. Comparisons were made 
using the χ2 test in case of categorical variables. Univariate 
and multivariate regression analyses were used to determine 
the ORs with the corresponding 95% CIs, where justified. 
The level of statistical significance was set at p < 0.05.
Ethical Approval
The study was conducted in compliance with the require-
ments of the medical ethical review board of the Univer-
sity Medical Center Groningen, the Netherlands.
RESULTS
Respondent Characteristics, the Prevalence of 
LARS, and Potential Influencing Factors
The total study population (N = 1259) consisted of 579 
men (46%) and 680 women (54%) with a median age of 
49 years (range, 18–85 y). All of the respondent character-
istics are shown in Table 1.
LARS in the General Dutch Population
We found that the sample representing the general Dutch 
population had a median LARS score of 16, ranging be-
tween 0 and 42. As Table 1 shows, 36.5% of the respon-
dents experienced LARS, with minor LARS significantly 
more prevalent than major LARS (24.3% vs 12.2%; 
p < 0.001). Minor and major LARS were slightly more 
prevalent among women than men. Sex, age, and BMI 
were not significantly associated with LARS (p = 0.155, 
p = 0.111, and p = 0.415).
Bowel Dysfunctions Associated With LARS
Constipation and FI were significantly associated with mi-
nor LARS (p < 0.005 and p < 0.001), whereas the associ-
ation with IBS was not significant. Univariate regression 
analysis confirmed that respondents with constipation 
or FI were 1.65 and 6.33 times more prone to experience 
minor LARS than respondents who did not have such 
dysfunctions (Table 2). As expected, the prevalence of 
constipation, FI, and IBS was highest in the respondents 
 experiencing major LARS (43.1%, 35.9%, and 13.7%; Ta-
ble 1). Univariate analysis confirmed that respondents 
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who had these bowel dysfunctions were more likely to ex-
perience major LARS than respondents without these dys-
functions (Table 2). Consequently, the use of laxatives and 
antidiarrheal medication was also highest in the group 
with major LARS (Table 1). The respondents who used 
laxatives or antidiarrheal medication were ≈9 to 93 times 
more prone to experience major LARS than respondents 
who did not use such medication (Table 2).
Other Factors Potentially Associated With LARS
Remarkably, when considering diabetes mellitus, we 
found that it was associated with both types of LARS 
TABLE 1.   The prevalence of LARS and of the potentially associated factors
Factors Total No LARS Minor LARS Major LARS
LARS prevalence, n (%) 1259 (100) 800 (63.5) 306 (24.3) 153 (12.2)
Demographic factors     
Sex, n (%)     
  Men 579 (46.0) 384 (66.3) 132 (22.8) 63 (10.9)
  Women 680 (54.0) 416 (61.2) 174 (25.6) 90 (13.2)
Age, median (range), y 49 (18–85) 50 (18–85) 50 (18–85) 46 (18–78)
BMI, median (range), kg/m2 25.5 (13.4–65.3) 25.5 (15.0–45.8) 25.6 (13.4–60.2) 25.6 (16.3–65.3)
Associated bowel dysfunctions, n (%)     
  Constipation 235 (18.7) 107 (13.4) 62 (20.3) 66 (43.1)
  Fecal incontinence 100 (7.9) 14 (1.8) 31 (10.1) 55 (35.9)
  Irritable bowel syndrome 57 (4.5) 23 (2.9) 13 (4.2) 21 (13.7)
Medication that could influence bowel function, n (%)     
  Laxatives* 85 (6.8) 27 (3.4) 22 (7.2) 36 (23.5)
  Antidiarrheal drugs* 23 (1.8) 1 (0.1) 6 (2.0) 16 (10.5)
Obstetric history     
Vaginal birth, n (%)     
  0 896 (71.2) 574 (71.8) 217 (70.9) 105 (68.6)
  ≥1 363 (28.8) 226 (28.3) 89 (29.1) 48 (31.4)
Comorbidities, n (%)     
  Diabetes mellitus 114 (9.1) 44 (5.5) 43 (14.1) 27 (17.6)
  Cerebrovascular accident 20(1.6) 13(1.6) 5 (1.6) 2 (1.3)
LARS = low anterior resection syndrome. Prevalences are reported as medians.
*Medications were used at least several times per month.
TABLE 2.   Univariate analysis of potential factors influencing LARS
Factors
Minor LARS Major LARS
OR (95% CI) p OR (95% CI) p
Associated bowel dysfunction
Constipation  <0.005  <0.001
  No Reference  Reference  
  Yes 1.65 (1.17–2.32)  4.91 (3.36–7.18)  
Fecal incontinence  <0.001  <0.001
  No Reference  Reference  
  Yes 6.33 (3.32–12.07)  31.51 (16.9–58.76)  
Irritable bowel syndrome  0.25  <0.001
  No Reference  Reference  
  Yes 1.5 (0.75–3.00)  5.38 (2.89–9.99)  
Medication used in case of bowel dysfunctions     
  Laxatives*  0.007  <0.001
  No Reference  Reference  
  Yes 2.22 (1.24–3.96)  8.81 (5.16–15.05)  
  Antidiarrheal drugs*  0.01  <0.001
  No Reference  Reference  
  Yes 15.98 (1.92–133.29)  93.31 (12.28–709.36)  
Comorbidities     
  Diabetes mellitus  <0.001  <0.001
  No Reference  Reference  
  Yes 2.81 (1.80–4.38)  3.68 (2.2–6.16)  
LARS = low anterior resection syndrome.
*Medications were used at least several times per month.
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(p < 0.001). The prevalence of minor and major LARS a-
mong respondents with diabetes mellitus was 37.7% and 
23.7%. Respondents who had diabetes mellitus were ≈3 
times more prone to experience minor LARS in compar-
ison with the respondents without diabetes mellitus (Ta-
ble 2). Moreover, these respondents were 3.7 times more 
likely to experience major LARS than the respondents 
without diabetes mellitus (Table 2). In contrast, neither 
cerebrovascular accidents nor vaginal birth were associ-
ated with either minor or major LARS.
Prevalence of LARS and Other Bowel 
Dysfunctions in Relation to Comorbidities
Of the total study population, 884 respondents (70.2%) did 
not report any comorbidity that could potentially have con-
tributed to the bowel dysfunction specified in the methods. 
The other 375 respondents (29.8%) had at least 1 of these 
comorbidities (Table 3). The presence of the comorbidi-
ties increased the likelihood of experiencing minor LARS 
≈2 times (OR = 1.95 (95% CI, 1.47–2.59); p < 0.001) and 
major LARS 3 times (OR = 3.07 (95% CI, 2.15–4.39); p 
< 0.001). Nevertheless, 21.7% of the respondents without 
comorbidities experienced minor LARS and 8.9% experi-
enced major LARS. Furthermore, we found that, irrespec-
tive of the comorbidities, symptoms typical for constipation 
were reported most often in cases of minor and major LARS 
(Fig. 1). Finally, we found the highest prevalence of FI in 
respondents with major LARS and comorbidities.
DISCUSSION
This study shows that LARS is not restricted to patients 
who had undergone low anterior resection but that it was 
also frequent among the general Dutch population. Mi-
nor and major LARS even occurred among respondents 
without any comorbidity that is known to influence bowel 
function. Furthermore, respondents with diabetes mel-
litus were significantly more prone to experience minor 
and major LARS. Therefore, without a baseline and know-
ledge of the medical background of an individual, minor 
or major LARS measured after resection should not be in-
terpreted straight away as poor functional outcome after 
surgery.
It is remarkable to observe that one third of the gene-
ral Dutch population experiences minor or major LARS, 
following the LARS score. This prevalence is high, espe-
cially when taking into account the prevalences of minor 
and major LARS after low anterior resection (22%–28% 
and 38%–62%).6 The prevalence of LARS in this study was 
comparable to the recent findings of Juul et al7 for ma-
jor LARS among the general Danish population. In our 
study we also described minor LARS and the relation of 
LARS with different comorbidities, other types of bowel 
dysfunction, and medication.
At first, it might be surprising that respondents who 
had not undergone a low anterior resection experienced 
LARS. However, when we take into account the relatively 
high prevalences of different bowel dysfunctions in non-
patient populations, our finding seems to be justified. For 
example, a Dutch study revealed that 24.5% of the general 
Dutch population had constipation and 7.9% had FI.9 Be-
cause symptoms included in the LARS score overlap with 
some symptoms of constipation and FI, the high preva-
lence of LARS that we found among the general popula-
tion is not surprising.
Originally, the LARS score was developed as a quick 
tool to assess the bowel function of patients after resec-
tion for rectal cancer.3 The high frequencies of LARS a-
mong the general population clearly show that minor and 
major LARS were already present in a considerable part 
of the population before resection. This finding indicates 
that if the LARS score is considered without determining 
a baseline, it might be misinterpreted. This in turn raises 
the question of how to interpret the LARS score to draw 
an objective conclusion regarding a patient’s functional 
outcome.
One might presume that the LARS score obtained 
after resection would be more objective if a baseline had 
been established before surgery. This seems logical, but, 
as reported by Thomas et al,13 preoperative screening for 
LARS is currently performed by perhaps only 10% of the 
surgeons in the Netherlands. Such unsystematic preoper-
ative screening might stem from the fact that the bowel 
function of many patients before low anterior resection 
was affected by rectal cancer, and a LARS score at that mo-
ment would not be a true reflection of their baseline.
This brings us to the question of whether normative 
values obtained from a general population might not be a 
better option for the baseline, as was proposed by Juul et al.7 
If so, the baseline would require correction for those factors 
that are significantly associated with LARS. We determined 
which factors, other than a low anterior resection, signifi-
cantly contributed to minor or major LARS in the general 
Dutch population. Previously, age, sex, BMI, and obstet-
ric history were described as being related to LARS.3,7,14,15 
In contrast, we found no significant  association between 
 minor or major LARS and these factors. This indicates that 
TABLE 3.   The prevalence of LARS in the subgroups with and 
without comorbidities
LARS status






Subgroup with  
comorbidities,  
n (%)
Total 1259 (100) 884 (100) 375 (100)
No LARS 800 (63.5) 613 (69.3) 187 (49.9)
Minor LARS 306 (24.3) 192 (21.7) 114 (30.4)
Major LARS 153 (12.2) 79 (8.9) 74 (19.7)
LARS = low anterior resection syndrome. Prevalences are reported as medians.
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these factors were probably not crucial for establishing the 
baseline LARS score. The difference of our outcomes, in 
terms of age and sex as cofactors, might be explained by 
the fact that we did not investigate patients but rather a 
sample representing the general population, and the age 
distribution of such a population is different from that 
of patients. Furthermore, to investigate whether comor-
bidities were associated with LARS, we looked at diabetes 
mellitus and cerebrovascular accidents that are known to 
occur frequently in the general population. Cerebrovascu-
lar accidents were not associated with LARS. Respondents 
with diabetes mellitus were significantly more prone to ex-
perience LARS. Consequently, this comorbidity should be 
taken into account when interpreting the LARS score.
Knowing that the general Dutch population is not free 
of comorbidities that can negatively influence bowel func-
tion, we also performed the analysis in a subpopulation 
without comorbidities to estimate the prevalence of LARS 
in theoretically healthy respondents. Remarkably, the 
prevalences of minor and major LARS were only slightly 
lower in this group. Nevertheless, approximately one third 
of the subpopulation experienced LARS. These observa-
tions bring us back to the question: how should we inter-
pret the LARS score after low anterior resection if we know 
that respondents who never have undergone abdominal 
operations or experience comorbidities that possibly in-
fluence bowel function already experience LARS? Con-
sidering the outcomes of this study, we agree with Ribas 
et al,16 who already indicated that the LARS score might 
overestimate the impact of LARS.
Finally, it is important to remember that LARS is a 
complex, multifactorial syndrome, involving more than 
FI and impaired bowel frequency.17,18 It has been shown 
that even specialists and colorectal care nurses, who rou-
tinely deal with patients after low anterior resection, do 
not have a thorough understanding of their patients’ prob-
lems in terms of bowel dysfunction.19 This hampers proper 

























































































FIGURE 1. The distribution of separate symptoms characteristic of bowel dysfunctions, such as fecal incontinence (FI) and constipation, in 
respondents experiencing (A) minor LARS and (B) major LARS. LARS = low anterior resection syndrome. Prevalences are reported as medians.
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the respondents with LARS were also diagnosed with con-
stipation, that ≈19% had FI, and that >7% experienced IBS 
shows that the LARS score does not provide precise insight 
into the nature of the bowel problem. Therefore, although 
the LARS score certainly helps to quickly assess postopera-
tive outcomes, we ask ourselves whether more specific diag-
nostic investigation, focused directly on constipation and/
or FI, would not be more efficient to guide the clinician 
toward effective treatment of patient bowel dysfunctions.
In this study, we were unable to analyze all of the pos-
sible comorbidities and other factors that might influence 
LARS. We are aware that there are more important factors 
that warrant future study. Another limitation to this study 
is that it was restricted to the Dutch population. Neverthe-
less, our results are in line with recent findings published 
by Juul et al,7 who reported on a study conducted in the 
population of Denmark. We are therefore confident that 
the main conclusions of this study might be generalized to 
other countries.
CONCLUSION
Minor and major LARS occur in a large part of the gene-
ral Dutch population and even in a healthy subgroup. This 
questions the original purpose for which the LARS score was 
developed. In our option, the LARS score can only be used to 
interpret the functional result of low anterior resection when 
a proper baseline measurement of each individual patient is 
considered. Moreover, because patients with LARS often ex-
perience constipation and/or FI, we ask ourselves whether 
direct investigation and diagnosis of these 2 conditions 
might not be more efficient to guide the clinician toward ef-
fective treatment of their patients’ bowel dysfunctions.
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